INTERCEPT Plasma: Journal Articles

1. JP Cazenave, C Waller, D Kientz, I Mendel, L Lin, M Jacquet, M Propst, W Liu, L Corash, D Sundin, L Defoin, N Messe, and JCOsselaer. An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment. Transfusion. 2010 Jan. [Epub ahead of print]
   > View abstract
   
   
2. J Irsch, L Pinkoski, L Corash, L Lin.  INTERCEPT plasma: comparability with conventional fresh-frozen plasma based on coagulation function – an in vitro analysis. Vox Sanguinis 2010: 98, 47–55
   > View abstract
   
3. N de Valensart, A Rapaille, E Goossenaerts, D Sondag-Thull, V Deneys. Study of coagulation function in thawed apheresis plasma for photochemical treatment by amotosalen and UVA. Vox Sang. 2009;96:213-218.
   > View abstract
4. JC Osselaer, C Debry, M Goffaux, et al. Coagulation function in fresh frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 2008 Jan;48(1):108-17.
   > View abstract
5. J Cid, L Ramiro, N Martínez, M Palomo, O Magallon, M Claparols, P Ortiz, L Puig, RP Pla. Quantitative and Qualitative Analysis of Proteins in Fresh Frozen Plasma Obtained from Whole Blood Donations and Prepared with Two Photochemical Treatments. Transfus Apher Sci. 2008 Oct;39(2):115-21.
   > View abstract
6. P Grellier, J Benach, M Labaied, S Charneau, H Gil, G Monsalve, R Alfonso, L Sawyer, L Lin, M Steiert, K Dupuis. Photochemical Inactivation with Amotosalen and Long-Wavelength Ultraviolet Light of Plasmodium and Babesia in Platelet and Plasma Components. Transfusion 2008 Aug;48(8):1676-84.
   > View abstract
7. P Schlenke, T Hervig, H Isola, ML Wiesel, et al. Photochemical Treatment of Plasma with Amotosalen and UVA Light: Process Validation in Three European Blood Centers. Transfusion 2008 Apr;48(4):697-705.
   > View abstract
8. HJ Alter. Pathogen Reduction: a Precautionary Principle Paradigm. Transfus Med Rev 2008 Apr;22(2):97-102.
   > View abstract
9. Y Singh, LS Sawyer, LS Pinkoski, et al. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006;46:1168-77
10. PD Mintz, NM Bass, LD Petz, et al. Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease. Blood 2006;107:3753-60
11. Mintz PD, Neff A, MacKenzie M, et al. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion 2006;46:1693-704
12. V Jauvin, RD Alfonso, B Guillemain, K Dupuis and HJ Fleury. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen. Transfusion 2005;45:1151-9
13. L Lin, MG Conlan, J Tessman, G Cimino and S Porter. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment. Transfusion 2005;45:1610-20
14. P de Alarcon, R Benjamin, M Dugdale, et al. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion 2005;45:1362-72
15. JP Allain, C Bianco, MA Blajchman, et al. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev 2005;19:110-26
16. L Corash, L Lin. Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease. Bone Marrow Transplant 2004;33:1-7
17. P Schlenke. Protection against Transfusion-Associated Graft-versus-Host Disease in Blood Transfusion: Is Gamma-Irradiation the Only Answer? Transfusion Med Hemo. 2004;31:24-31
18. L Corash. Pathogen reduction technology: methods, status of clinical trials, and future prospects. Curr Hematol Rep 2003;2:495-502
19. WC Van Voorhis, LK Barrett, RT Eastman, R Alfonso and K Dupuis. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003;47:475-9
20. J Hambleton, D Wages, L Radu-Radulescu, et al. Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin. Transfusion 2002;42:1302-7
21. S Wollowitz. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 2001;38:4-11